Samsung Biologics has announced its intent to acquire PolyPeptide Group, a leading contract development and manufacturing organization (CDMO) specializing in…
Read More
Anixa Biosciences Secures Key Patent for Breast Cancer Vaccine Technology in South Korea, Expanding Global Intellectual Property Portfolio
Anixa Biosciences has achieved a significant milestone in its quest to develop a preventive vaccine for breast cancer, securing a…
Read More
Expanding Screenings for Type 1 Diabetes Reveals a Wider Burden Than Previously Understood
A paradigm shift in the approach to identifying type 1 diabetes (T1D) is being advocated, as new research suggests that…
Read More
NICE Recommends Nucala for Severe Asthma and COPD, Expanding Access to Advanced Biologic Therapy in the UK
In a significant development for respiratory healthcare in the United Kingdom, the National Institute for Health and Care Excellence (NICE)…
Read More
Expanding Screening for Type 1 Diabetes in Children Could Identify More Cases
A significant shift in the approach to identifying type 1 diabetes in children is being advocated for, with a new…
Read More
FDA Approves Langlara, an Interchangeable Biosimilar for Diabetes Management, Expanding Patient Access and Treatment Options
Sunshine Lake Pharma, Lannett Company, and its wholly owned subsidiary Lanexa Biologics have achieved a significant milestone in diabetes care…
Read More
The Crucial Role of Payload Linker Innovation in the Rapidly Expanding Antibody-Drug Conjugate Market
Combining the targeted precision of monoclonal antibodies with the potent destructive power of cytotoxic payloads, Antibody-Drug Conjugates (ADCs) represent a…
Read More
